• Policy
• Security elaboration/ ultra-high-priced new drug coverage
• by Kim, Jung-Ju Aug 5, 2022 06:04am

• Policy
• MOHW reluctant to CVS's request to expand SRADs
• by kang, hae-kyung Aug 5, 2022 06:04am

• Company
• Celltrion, applies for Phase III U.S. Targeting
• by Lee, Seok-Jun Aug 5, 2022 03:32am

• Company
• Oncaspar changed supplier
• by Eo, Yun-Ho Aug 5, 2022 03:28am

• Company
• Samjin, will develop new drugs with AI company in Canada
• by Lee, Seok-Jun Aug 5, 2022 03:28am

• Policy
• Biogen’s Alzheimer’s disease TX entry unclear in Korea
• by Lee, Hye-Kyung Aug 4, 2022 06:05am

• Company
• Chinese partner terminates agreement with Medytox
• by Nho, Byung Chul Aug 4, 2022 06:04am

• Company
• MSD Korea to introduce cancer drug Welireg to Korea
• by Eo, Yun-Ho Aug 3, 2022 06:00am

• Company
• Competitivity of K-Pharma-Bio manufacturing facilities rises
• by Lee, Seok-Jun Aug 3, 2022 06:00am

• Company
• Lilly appoints new CEO Christopher J. Stokes
• by jung, sae-im Aug 3, 2022 06:00am